What patients and families need to know
Training patients’ own immune cells to recognize and destroy hard-to-treat solid tumors
Children’s National Hospital’s Center for Cancer and Immunology Research, led by Catherine “Cath” Bollard, M.B.Ch.B., is forging new frontiers in cancer immunotherapy, which reprograms a patient’s own immune cells so they learn to recognize and destroy cancer cells – and just cancer cells. This short video explains the lab’s use of a novel immune-directed, T-cell therapy to treat high-risk children and young adults with solid tumors who have few therapeutic options and face uncertain futures. STAT editors chose this research paper as one of the finalists in STAT Madness 2020, a bracket-style competition to highlight the year’s best biomedical innovations.
Vote NOW for Children’s National!
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.
Make it happen